TNFSF12 and neoplasm: TWEAK (Tumor necrosis factor-like weak inducer of apoptosis), as a member of the tumor necrosis factor (ligand) superfamily, it has been proven in clinical research to have pro-apoptotic activity against specific tumor cells and is very likely to be involved in the pathogenesis of chronic inflammatory diseases.